Back to Agenda
Session 1
Speaker(s)
Viola Macolic Sarinic, DRSC, MD, MSC
Scientific Officer, European Medicines Agency, Netherlands
GVP Module Product – or Population-Specific Considerations III: Pregnant and Breastfeeding Women – Where We Are
Ulla Wändel Liminga, DrMed, MS, RPH
Scientific Director Pharmacology/Toxicology, Medical Products Agency (MPA), Sweden
COVID-19 Pandemic – Challenges and Lessons Learned
Corinne de Vries, PHD, MA, MSC
EMA liaison official to the US FDA, European Medicines Agency, Netherlands
EMA Pregnancy Strategy
David John Lewis, PHD
Former Head QPPV PRRC Office, Patient Safety & Pharmacovigilance, Novartis Pharma Gmbh, Switzerland
IMI Conception Consortium: Optimising Data Collection in Pregnant and Breastfeeding Women
Have an account?
